Project details
- Project period
- 1 Oct 2024 - 30 Sep 2026
- Total cost
- €1 250 000,00
- Global Health EDCTP3 funding
- €1 250 000,00
- Call identifier
- HORIZON_HORIZON-JU-GH-EDCTP3-2024-Mpox
- Status
- In progress
- Project type
- Research and Innovation Actions (RIA)
- Disease area
- Emerging or re-emerging infectious diseases
- Intervention type
- Surveillance tools
- Overarching topic
- Health security
Consortium map
Coordinator
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
- Location
- Rotterdam, Netherlands
- EU contribution
- €325 000,00
- Total cost
- €325 000,00
Beneficiaries
STANSILE LTD
- Location
- Nyarugenge, Rwanda
- EU contribution
- €420 000,00
- Total cost
- €420 000,00
RWANDA BIOMEDICAL CENTER
- Location
- Kigali, Rwanda
- EU contribution
- €40 000,00
- Total cost
- €40 000,00
DANMARKS TEKNISKE UNIVERSITET
- Location
- KONGENS LYNGBY, Denmark
- EU contribution
- €145 000,00
- Total cost
- €145 000,00
UNIVERSIDAD DE CASTILLA - LA MANCHA
- Location
- CIUDAD REAL, Spain
- EU contribution
- €25 000,00
- Total cost
- €25 000,00
THE GOOD SAMARITAN FOUNDATION
- Location
- MOSHI, Tanzania
- EU contribution
- €75 000,00
- Total cost
- €75 000,00
INSTITUT NATIONAL DE SANTE PUBLIQUE
- Location
- Bujumbura, Burundi
- EU contribution
- €75 000,00
- Total cost
- €75 000,00
UNIVERSITE CATHOLIQUE DE BUKAVU
- Location
- BUKAVU, Democratic Republic of the Congo
- EU contribution
- €145 000,00
- Total cost
- €145 000,00
Related projects
Understanding mpox infections during pregnancyThe PREGMPOX project is attempting to find out why mpox virus infections are particularly harmful to pregnant women.
A platform for evaluating Lassa fever treatmentsThe INTEGRATE project is creating a clinical trial platform able to support efficacy studies on multiple Lassa fever therapeutics.
Enhancing genomic surveillance in the Great Lakes regionThe GREAT-LIFE project is building a genomics-based infrastructure to track existing and new infectious disease threats and...